ClinicalTrials.gov record
Terminated No phase listed Observational Results available

Genetic Testing in Screening Patients With Metastatic or Unresectable Colon or Rectal Cancer for a COLOMATE Trial

ClinicalTrials.gov ID: NCT03765736

Public ClinicalTrials.gov record NCT03765736. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced May 21, 2026, 1:11 AM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

COLOMATE: Colorectal Cancer Liquid Biopsy Screening Protocol for Molecularly Assigned Therapy

Study identification

NCT ID
NCT03765736
Recruitment status
Terminated
Study type
Observational
Phase
Not listed
Lead sponsor
Academic and Community Cancer Research United
Other
Enrollment
199 participants

Conditions and interventions

Eligibility (public fields only)

Age range
18 Years and older
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Apr 19, 2020
Primary completion
Nov 30, 2023
Completion
Nov 30, 2023
Last update posted
Aug 28, 2025

2020 – 2023

United States locations

U.S. sites
18
U.S. states
16
U.S. cities
17
Facility City State ZIP Site status
Mayo Clinic in Arizona Scottsdale Arizona 85259
UC San Diego Moores Cancer Center La Jolla California 92093
USC / Norris Comprehensive Cancer Center Los Angeles California 90033
Cedars Sinai Medical Center Los Angeles California 90048
MedStar Georgetown University Hospital Washington D.C. District of Columbia 20007
Mayo Clinic in Florida Jacksonville Florida 32224-9980
Emory University Hospital/Winship Cancer Institute Atlanta Georgia 30322
University of Chicago Comprehensive Cancer Center Chicago Illinois 60637
Dana-Farber Cancer Institute Boston Massachusetts 02215
Mayo Clinic in Rochester Rochester Minnesota 55905
Washington University School of Medicine St Louis Missouri 63110
Rutgers Cancer Institute of New Jersey New Brunswick New Jersey 08903
Memorial Sloan Kettering Cancer Center New York New York 10065
Duke University Medical Center Durham North Carolina 27710
Allegheny General Hospital Pittsburgh Pennsylvania 15212
Vanderbilt University/Ingram Cancer Center Nashville Tennessee 37232
M D Anderson Cancer Center Houston Texas 77030
Aurora Cancer Care-Milwaukee Milwaukee Wisconsin 53209

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT03765736, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Aug 28, 2025 · Synced May 21, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete protocol, eligibility criteria, and contact information for NCT03765736 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →